Ivermectin

The peak of COVID-19 infections might be behind us – at least until the next “variant of concern” of the SARS-CoV-2 virus appears – but the scourge of long COVID lives on.  And on.

Join ACSH directors of bio-sciences and chemistry Cameron English and Dr. Josh Bloom as they break down these stories on episode 15 of the Science Dispatch podcast:

About a week ago, news outlets reported that a large randomized controlled trial showed that ivermectin had no impact on COVID.

Disclaimer and Context

Here’s the problem. The Australian sea lions, and there are roughly 10,000, continue to decline in part because of endemic hookworm, a parasite that kills the pups.

  Are Doctors Indifferent to the plight of their dying patients?

Recent rumors speculate that ivermectin and Pfizer's promising experimental Covid drug PF-07321332 (1) are both inhibitors of the viral main protease (Mpro) (2) and can therefore be used

Telling stories about health science, 

This will mark the fourth article in a little over a week on ivermectin on our website, and we are not alone.

Dr. Dan Stein recently presented a dataset representing an ongoing meta-analysis of patients' responses with COVID-19 to ivermectin.